Brian C. Broderick’s Ironwood Pharmaceuticals IRWD Stock Holding History

Brian C. Broderick’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$63.2K	Hold	18,000	–	–	0.01%	92
2025 Q4	$60.7K	Hold	18,000	–	–	0.01%	83
2025 Q3	$23.6K	Hold	18,000	–	–	﹤0.01%	86
2025 Q2	$12.9K	Sell	18,000 -15,000	-45%	-$11.8K	﹤0.01%	86
2025 Q1	$48.5K	Hold	33,000	–	–	0.01%	84
2024 Q4	$146K	Hold	33,000	–	–	0.03%	82
2024 Q3	$136K	Hold	33,000	–	–	0.03%	84
2024 Q2	$215K	Sell	33,000 -3,000	-8%	-$21.2K	0.04%	81
2024 Q1	$314K	Hold	36,000	–	–	0.07%	77
2023 Q4	$412K	Hold	36,000	–	–	0.1%	62
2023 Q3	$347K	Hold	36,000	–	–	0.1%	65
2023 Q2	$383K	Sell	36,000 -1,000	-3%	-$10.7K	0.1%	63
2023 Q1	$389K	Sell	37,000 -42,000	-53%	-$470K	0.11%	61
2022 Q4	$979K	Hold	79,000	–	–	0.29%	48
2022 Q3	$818K	Sell	79,000 -4,500	-5%	-$51K	0.26%	51
2022 Q2	$963K	Sell	83,500 -12,500	-13%	-$147K	0.29%	49
2022 Q1	$1.21M	Sell	96,000 -6,946	-7%	-$79.6K	0.31%	50
2021 Q4	$1.2M	Sell	102,946 -38,404	-27%	-$471K	0.29%	51
2021 Q3	$1.85M	Sell	141,350 -2,500	-2%	-$32.3K	0.49%	47
2021 Q2	$1.85M	Sell	143,850 -8,250	-5%	-$94.4K	0.49%	48
2021 Q1	$1.7M	Sell	152,100 -5,000	-3%	-$52.8K	0.49%	47
2020 Q4	$1.79M	Buy	157,100 +55,000	+54%	+$602K	0.53%	45
2020 Q3	$918K	Sell	102,100 -1,500	-1%	-$14.9K	0.29%	52
2020 Q2	$1.07M	Hold	103,600	–	–	0.36%	52
2020 Q1	$1.04M	Sell	103,600 -8,581	-8%	-$101K	0.41%	51
2019 Q4	$1.49M	Sell	112,181 -211,691	-65%	-$2.33M	0.48%	50
2019 Q3	$2.78M	Sell	323,872 -5,361	-2%	-$52.1K	0.96%	40
2019 Q2	$3.6M	Sell	329,233 -63,871	-16%	-$716K	1.26%	36
2019 Q1	$3.73M	Hold	393,104	–	–	1.33%	33
2018 Q4	$3.41M	Hold	393,104	–	–	1.44%	30
2018 Q3	$6.08M	Sell	393,104 -58,148	-13%	-$919K	2.06%	23
2018 Q2	$7.23M	Sell	451,252 -127,199	-22%	-$1.88M	2.64%	14
2018 Q1	$7.47M	Sell	578,451 -3,105	-0.5%	-$38.7K	2.8%	9
2017 Q4	$7.3M	Buy	581,556 +409,052	+237%	+$5.34M	2.67%	13
2017 Q3	$2.28M	Hold	172,504	–	–	0.82%	43
2017 Q2	$2.73M	Hold	172,504	–	–	1.01%	34
2017 Q1	$2.46M	Hold	172,504	–	–	1.01%	35
2016 Q4	$2.21M	Hold	172,504	–	–	0.96%	35
2016 Q3	$2.29M	Sell	172,504 -11,940	-6%	-$140K	0.98%	35
2016 Q2	$2.02M	Hold	184,444	–	–	0.85%	37
2016 Q1	$1.69M	Sell	184,444 -2,232	-1%	-$18.4K	0.73%	46
2015 Q4	$1.81M	Hold	186,676	–	–	0.81%	42
2015 Q3	$1.63M	Hold	186,676	–	–	0.75%	48
2015 Q2	$1.89M	Hold	186,676	–	–	0.8%	45
2015 Q1	$2.5M	Sell	186,676 -7,164	-4%	-$94K	1.04%	37
2014 Q4	$2.49M	Sell	193,840 -4,776	-2%	-$54.7K	1.05%	36
2014 Q3	$2.16M	Hold	198,616	–	–	0.96%	36
2014 Q2	$2.55M	Sell	198,616 -16,119	-8%	-$175K	1.17%	33
2014 Q1	$2.22M	Sell	214,735 -7,164	-3%	-$80.6K	1.09%	33
2013 Q4	$2.16M	Hold	221,899	–	–	1.07%	33
2013 Q3	$2.2M	Sell	221,899 -4,776	-2%	-$46.9K	1.23%	31
2013 Q2	$1.89M	Buy	+226,675	New	+$2.75M	1.13%	28

Other funds holding IRWD

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Brian C. Broderick's IRWD Position: Q1 2026 in Review

Brian C. Broderick held its Ironwood Pharmaceuticals (IRWD) position steady in Q1 2026 at 18,000 shares worth $63.2K. The position accounts for 0.01% of the portfolio, ranked #92.

Brian C. Broderick first reported a position in IRWD in Q2 2013 and has held it in 52 quarters since. The position peaked at $7.47M in Q1 2018. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

Brian C. Broderick held 18,000 shares of Ironwood Pharmaceuticals worth $63.2K as of Q1 2026.
Brian C. Broderick left its Ironwood Pharmaceuticals share count unchanged in Q1 2026.
Ironwood Pharmaceuticals made up 0.01% of Brian C. Broderick's portfolio in Q1 2026, its #92 holding.
Brian C. Broderick first reported a position in Ironwood Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
Brian C. Broderick's Ironwood Pharmaceuticals position peaked at $7.47M in Q1 2018.
226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Brian C. Broderick's 13F filing for Q1 2026, filed 7 May 2026.